Recall Record

Northridge, CA, United States

Medtronic Inc. recalls

38 recalls recorded since 2018, most recently on 11 March 2026. 25 are listed as ongoing. Status and classification are as published by the FDA.

Recalls38
Ongoing (FDA)25
Terminated or completed13
Class I (FDA)6

Ongoing Class II Medical devices

Recall started
11 March 2026
Reason
Ventricular fibrillation (VF) occurred during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implanted. The observation is caused by an interaction between the Sphere-9 catheter current flow and a safety feature built into Biotronik ICDs and CRT Ds. Medtronic recommends physicians use increased caution when using the Sphere-9 catheter for RF ablation therapy in patients implanted with a Biotronik ICD/CRT-D system, and to ensure external defibrillation systems are readily available.
Distribution
Worldwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1948-2026

Ongoing Class II Medical devices

Recall started
4 December 2025
Reason
Stents may be impacted by a Nitinol anomaly which causes a reduced stent diameter when deployed and corresponding reduced radial force. Issue may result in stent migration.
Distribution
Worldwide - US Nationwide and the countries of Argentina, Australia, Austria, Belgium, Chile, Colombia, Costa Rica, Denmark, Dominican Republic, Finland, Germany, Jordan, Lebanon, Malaysia, Netherlands, New Zealand, Peru, Poland, Russia, Singapore, Spain, Switzerland, Taiwan, Thailand, United Arab
Initiated
Voluntary: Firm initiated
Recall number
Z-1098-2026

Ongoing Class II Medical devices

Recall started
29 October 2025
Reason
There is a potential for delayed time to high-voltage (HV) therapy should a rare sequence of events occur.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0726-2026

Ongoing Class II Medical devices

Recall started
18 June 2025
Reason
In prior SmartSync application versions, the Abort button stopped the test that was selected. During an induction test, there was a limited window of time for the user to abort a therapy, thereby limiting the user's ability to cancel a high voltage therapy delivery.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2168-2025, Z-2169-2025

Ongoing Class II Medical devices

Recall started
17 June 2025
Reason
A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no reset has actually occurred and there are no parameter changes or loss of diagnostics. Prior to this software update, if an erroneous SmartSync message was displayed, confusion regarding the message could have caused a clinician to consider an unnecessary system revision. Medtronic has received 39 reports of this display error with two instances of unnecessary device explant through 30 April 2025.
Distribution
Worldwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2127-2025, Z-2128-2025

Ongoing Class II Medical devices

Recall started
29 April 2025
Reason
Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection, hematoma, or temporary impairment.
Distribution
International distribution of the country of UK. No US distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1924-2025

Ongoing Class II Medical devices

Recall started
11 July 2024
Reason
Medtronic CareLink 2090 programmers with serial number prefixes PKK0 and PKK1 have the potential for autonomous cursor motion when Finger Touchscreen capability is enabled by software version 3.2 or higher.
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-3152-2024

Ongoing Class II Medical devices

Recall started
16 April 2024
Reason
Potential for manufacturing defect. Weld crack led to devices failing at the leak check step in manufacturing.
Distribution
Worldwide - US Nationwide distribution in the states of CA, CT, FL, IN, MA, MI, NC, NH, NJ, NM, NY, OH, TX, VA and the countries of Australia, Austria, Bulgaria, Canada, China, Croatia, Czech Republic, France, Georgia, Germany, Greece, Guadeloupe, Iceland, Ireland, Italy, Jordan, Kosovo, Latvia, Mol
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2197-2024, Z-2206-2024, Z-2190-2024, Z-2209-2024, Z-2210-2024, Z-2205-2024, Z-2207-2024, Z-2211-2024, Z-2202-2024, Z-2208-2024, Z-2200-2024, Z-2204-2024 and 11 more

Ongoing Class II Medical devices

Recall started
16 February 2024
Reason
There is a potential for sterile package breach.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Canary Islands, Colombia, Finland, Germany, Netherlands, Portugal, Spain, Switzerland, United Arab Emirates, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-1317-2024

Ongoing Class II Medical devices

Recall started
7 December 2023
Reason
During internal review of Polaris battery assembly data from the HiPot operation, a test systems engineer noticed that some batteries had gone through the High Potential test twice. This was able to occur because the test screen did not prevent retesting after a failure. Some batteries were therefore retested and passed.
Distribution
US Nationwide distribution in the state of Florida.
Initiated
Voluntary: Firm initiated
Recall number
Z-0779-2024

Completed Class II Medical devices

Recall started
20 November 2023
Reason
Seal defects could compromise the ability of the product packaging to maintain sterility.
Distribution
US Nationwide distribution in the state of MN.
Initiated
Voluntary: Firm initiated
Recall number
Z-0623-2024

Ongoing Class II Medical devices

Recall started
3 November 2023
Reason
It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.
Distribution
US and Australia, Austria, Belgium, Brunei Darussalam, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Macao, Malaysia, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Puerto Rico, Saudi Ar
Initiated
Voluntary: Firm initiated
Recall number
Z-0421-2024

Ongoing Class II Medical devices

Recall started
12 October 2023
Reason
The Mo.Ma Ultra device manifold is labelled with 2 stickers, an inferior and superior sticker, one on each side of the manifold. These stickers label the common carotid artery (CCA) proximal balloon and external carotid artery (ECA) distal balloon inflation and deflation ports. Both sides of the complaint units manifold were labelled with the superior label leading to an incorrect identification of the proximal and distal inflation /deflation ports when viewing the devices from the inferior side.
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Armenia, France, Germany, Iraq, Italy, Japan, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0321-2024, Z-0322-2024, Z-0320-2024

Ongoing Class II Medical devices

Recall started
14 July 2022
Reason
Update to IFU provides a manual deployment workaround method to help mitigate potential harms related to partial stent deployment.
Distribution
worldwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1644-2022

Ongoing Class II Medical devices

Recall started
24 June 2022
Reason
Luer has balloon diameter printed as "2.25mmx12mm" instead of the correct diameter, "2.5mmx12mm" as reflected on the product outer packaging.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1483-2022

Ongoing Class I Medical devices

Recall started
5 May 2022
Reason
Batteries for the HVAD system have a weld defect affecting internal components within the HVAD battery, resulting in the battery to malfunction and no longer provide power or prevent the battery from holding a complete charge or properly recharging.
Distribution
Worldwide Distribution. US nationwide, Austria, Belgium, Finland, France, Germany, Hungary, Italy, Netherlands, New Zealand, North Macedonia, Norway, Poland, Spain, Switzerland, and the United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-1266-2022

Ongoing Class I Medical devices

Recall started
14 April 2022
Reason
The pump may have a welding defect that can lead the pump to malfunction. The issue is under investigation by the firm. It is suspected that a weld defect on the center post cap may allow moisture into the center post and corrode the magnets that keep the impeller rotating concentrically, leading to unintended contact between the center post and impeller. If this occurs, it may affect blood flow through the pump. The issue may present clinical signs and symptoms that resemble pump thrombosis.
Distribution
Worldwide distribution - US Nationwide DE and TX. There was no military/government distribution. The countries of Germany and Japan.
Initiated
Voluntary: Firm initiated
Recall number
Z-1207-2022

Ongoing Class II Medical devices

Recall started
30 March 2022
Reason
Errors and inconsistencies that were identified in the Instruction for Use (IFU), Emergency Responder Guide (ERG), and Patient Manual (PM) for the HeartWare Ventricular Assist Device (HVAD) system.
Distribution
Worldwide Distribution: US (nationwide) and OUS to countries of: Australia, Austria, Belgium, Denmark, France, Germany, Greece, Hungary, INDIA, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Poland, Slovakia, South Africa, Spain, Switzerland, Turkey, United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-1110-2022

Ongoing Class I Medical devices

Recall started
2 March 2022
Reason
There is potential for the capsule bond to break during the procedure.
Distribution
US Nationwide and the countries of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0927-2022

Terminated Class III Medical devices

Recall started
23 March 2021
Terminated
4 August 2026
Reason
Firm received increased number of reports that VenaSeal dispensing systems are not effectively advancing the adhesive forward through the delivery catheter.
Distribution
Distributed nationwide to MA, NY, VT, NH, ME
Initiated
Voluntary: Firm initiated
Recall number
Z-1564-2021

Terminated Class II Medical devices

Recall started
16 March 2021
Terminated
15 April 2024
Reason
Incorrect size printed on the device; packaging is labeled correctly.
Distribution
US Nationwide distribution in the states of NC, CO, CA, AZ, MT, MO.
Initiated
Voluntary: Firm initiated
Recall number
Z-1532-2021

Ongoing Class II Medical devices

Recall started
26 February 2021
Reason
Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug could result in inaccurate elevated sensor glucose readings.
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1606-2021, Z-1602-2021, Z-1613-2021, Z-1609-2021, Z-1601-2021, Z-1612-2021, Z-1614-2021, Z-1617-2021, Z-1615-2021, Z-1603-2021, Z-1605-2021, Z-1610-2021 and 8 more

Ongoing Class II Medical devices

Recall started
12 November 2020
Reason
Incomplete basal rate information may be transmitted leading to a potential for inappropriate change in therapy. During data upload, radio frequency (RF) interference can occur at any point from surrounding devices or equipment that may affect the data transfer between the insulin pump and the CareLink Personal or CareLink System Software.
Distribution
U.S. Nationwide O.U.S. Worldwide Refer to Associated Documents and uploaded Consignee Lists/Spreadsheets. -Australia New Zealand -Canada -EMEA -Greater China -India -Japan -Latin America -South Korea -Southeast Asia -US
Initiated
Voluntary: Firm initiated
Recall number
Z-0843-2021

Terminated Class II Medical devices

Recall started
15 July 2020
Terminated
18 February 2022
Reason
As a result of the release of new software version to CareLink Personal website, the IOS app for the Continuous Monitoring Glucose system stopped automatically uploading data to the website.
Distribution
International distribution including in the countries of EMEA - Austria, Belgium, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kuwait, Latvia, Luxembourg, The Netherlands, Poland, Portugal, Romania, Saudi Arabia, Serbia, Slovakia, Sl
Initiated
Voluntary: Firm initiated
Recall number
Z-2980-2020

Completed Class II Medical devices

Recall started
13 July 2020
Reason
The previous software application version (1.1.300) is missing a decimal separator (a comma) for parameter range guidance values displayed on some of the programming screens: Catheter, Reservoir, Infusion, Bolus, myPTM, and Alarm.
Distribution
Foreign Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0522-2024

Ongoing Class II Medical devices

Recall started
30 April 2020
Reason
Missing solder battery connection, which could interrupt power of insulin pump.
Distribution
Worldwide distribution - U.S. Nationwide Distribution in the state of MD and the countries of Canada, Netherlands, Norway. ***Model 630G distributed in Canada and Model 670G distributed in US ***MODEL640G Distributed OUS ONLY*** OUS: Australia, Canada, Netherlands and Norway.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0516-2021, Z-0518-2021, Z-0517-2021

Terminated Class II Medical devices

Recall started
10 April 2020
Terminated
27 April 2021
Reason
Internal testing results showed endotoxin-related test result did not meet specifications for implantable insulin pump. If pumps have higher than allowed endotoxin levels, patients may have an effect of fever, hypotension, anaphylactic shock, hyperglycemia, or diabetic ketoacidosis (DKA), potentially followed by secondary multi-organ failure (primarily renal and hepatic) and/or death.
Distribution
No US Distribution. OUS: Netherlands, France, and Sweden
Initiated
Voluntary: Firm initiated
Recall number
Z-2206-2020

Ongoing Class II Medical devices

Recall started
28 January 2020
Reason
Blades do not fit the McGRATH MAC video laryngoscope handle or were tight fitting on the handles which may result in a change in optical performance as displayed on the video screen
Distribution
Worldwide distribution - US Nationwide and countries Australia, Canada, New Zealand, India, Korea, Japan, Indonesia, Malaysia, Philippines, Singapore, Vietnam, Latin America, France, Switzerland. Italy, Belgium, Germany, Netherlands, Denmark, Poland, Austria, Czech Republic, Croatia, Spain, Finland,
Initiated
Voluntary: Firm initiated
Recall number
Z-1408-2020

Ongoing Class I Medical devices

Recall started
21 November 2019
Reason
There have been reported incidents of a loose reservoir that can no longer be locked into the pump. The reservoir can become loose due to a broken or missing retainer ring that prevents a proper lock. If the reservoir is not properly locked into the pump, it could lead to over or under delivery of insulin, which could then result in hypoglycemia or hyperglycemia.
Distribution
US:AK,AL,AR,AZ,BM,CA,CO,CT,DC,DE,FL,GA,HI,IA,ID,IL,IN,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,ND,NE,NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY OUS: France, Germany, UK, Italy, Netherlands, Spain, Sweden, Israel, Norway, Austria, Belgium, Denmark, Czech Repub
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0955-2020, Z-0958-2020, Z-0957-2020, Z-0956-2020

Terminated Class II Medical devices

Recall started
21 May 2019
Terminated
7 October 2020
Reason
Fifteen affected devices were distributed worldwide, which were mislabeled with an incorrect size. In all cases, the actual surgical heart valves are larger than what was indicated on the boxes and jar labels.
Distribution
Worldwide distribution - US Nationwide distribution in the states of TN, NY, NJ, and countries of France, Italy, Libya, Poland, Spain.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1884-2019, Z-1881-2019, Z-1880-2019, Z-1882-2019, Z-1883-2019

Ongoing Class II Medical devices

Recall started
20 May 2019
Reason
Customers using the firm's continuous glucose monitoring system application on an iPhone, iPad or iPod Touch with ios software version 12, 12.1, or 12,2 are likely to experience a shortened transmitter battery life (approximately 4-5 days instead of the normal 7 days or more) after a full charge.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2106-2020

Ongoing Class II Medical devices

Recall started
3 October 2018
Reason
Reports of occurrences in which insulin pumps with version 4.10 software have failed to make expected audio sounds during alerts, alarms or sirens. This could cause a user to miss system notifications, alarms or sirens associated with how the pump is working, and with high and low glucose alerts.
Distribution
US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, VT, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA, WI, WV, and WY
Initiated
Voluntary: Firm initiated
Recall number
Z-0683-2019

Terminated Class I Medical devices

Recall started
7 August 2018
Terminated
29 March 2024
Reason
There is a potential security vulnerability related to the use of the remote controller accessories with the insulin pumps.
Distribution
Distribution was nationwide to consumers and distributors. There was no government/military distribution. Foreign distribution was made to Algeria, Australia, Austria, Belgium, Brazil, Canada, China, Croatia, Czech Republic, Denmark, Estonia, Faroe Islands, Finland, France, Germany, Greece, Hu
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0178-2020, Z-0177-2020

Terminated Class II Medical devices

Recall started
4 July 2018
Terminated
6 June 2022
Reason
The application may be closed by the operating system without alerting the user the app is no longer running or communicating with the transmitter resulting in the user not receiving alerts that could be associated with hypoglycemic or hyperglycemic events.
Distribution
Distribution was only made OUS. Countries involved are: Austria, United Arab Emirate, Australia, Belgium, Switzerland, Chile, Colombia, Czech Republic, Germany, Denmark, Spain, Finland, France, United Kingdom, Hungary, Ireland, Israel, Iceland, Italy, Republic of Korea, Luxembourg, Netherlands, No
Initiated
Voluntary: Firm initiated
Recall number
Z-1282-2019

Terminated Class II Medical devices

Recall started
16 May 2018
Terminated
30 June 2020
Reason
CONTOUR PLUS LINK 2.4 meter with an incorrect unit of measure was included into meter kits and distributed. This meter contains the incorrect unit of measure mg/dL instead of mmol/L.
Distribution
International Distribution to Slovakia only.
Initiated
Voluntary: Firm initiated
Recall number
Z-3201-2018

Terminated Class II Medical devices

Recall started
24 April 2018
Terminated
2 May 2022
Reason
The MiniMed Paradigm Veo insulin pump has an error that impacts the Arabic language translation.This translation error occurs in the Predictive Alerts setting screen, which allows user to program alerts that will sound if users are predicted to reach their pre-set low or high sensor glucose values.
Distribution
International only. No U.S. distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-2377-2018

Terminated Class II Medical devices

Recall started
10 October 2017
Terminated
26 March 2021
Reason
Due to a time conversion error, data uploaded from the iPro(TM)2 recorder to the CareLink iPro software using the new CareLink iPro Uploader feature may result in incorrect reports. This pertains only to reports generated between September 23, 2017 and September 27, 2017 that used the new CareLink iPro Uploader feature.
Distribution
Worldwide Distribution - US Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0670-2018

Terminated Class I Medical devices

Recall started
26 September 2017
Terminated
27 April 2021
Reason
Complaints regarding 6F Taiga guide catheter tip detachment and/or tip splitting.
Distribution
Japan
Initiated
Voluntary: Firm initiated
Recall number
Z-1207-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.